Damon Runyon Cancer Research Foundation
Damon Runyon-Rachleff Innovation Award
 |
|
|
|
|
|
||||||||||||||||
|
|
|
|
|
|
||||||||||||||||
|
|
|
|
|
|
||||||||||||||||
|
|
|
|
|
|
||||||||||||||||
|
|
|
|
|
|
||||||||||||||||
|
|
|
|
|
|
||||||||||||||||
***For extraordinary assistant professors within the first three years of their UTL and MCL faculty appointments who can spend 80% of their time conducting research (please see eligibility criteria below).
Their proposals must contain "high risk/high reward ideas hat have the potential to significantly impact our understanding of and/or approaches to the prevention, diagnosis or treatment of cancer."
Sponsor's Program Overview and Pre-proposal Guideiines websites
(Please see eligibility requirements below
because Stanford policy has stricter requirements.)
Pre-proposal deadline: June 1, 2009
Number of applicants: unlimited (no internal seelection process is required)
Amount of funding
$450,000 in total direct costs over 3 years.
The Award cannot be used for indirect costs or institutional overhead.
Program:
The Damon Runyon-Rachleff Innovation Award is designed to provide support for the next generation of exceptionally creative thinkers with “high risk/high reward” ideas that have the potential to significantly impact our understanding of and/or approaches to the prevention, diagnosis or treatment of cancer.
The Innovation award is specifically designed to provide funding for extraordinary early career researchers who have an innovative new idea but lack sufficient preliminary data to obtain traditional funding. It is not designed to fund incremental advances. The research supported by the award must be novel, exceptionally creative and, if successful, have the strong potential for high impact in the cancer field.
- Applicants (including non-U.S. citizens) must be conducting independent research at a U.S. research institution.
- Basic and translational/clinical projects will be considered. Applications will be accepted from all scientific disciplines provided that the proposed research meets the selection criteria.
- Applicants with a background in multiple disciplines are especially encouraged to apply.
- Joint submission from collaborators working in different disciplines will be considered. (The collaborators will share the $450,000 award.)
- Applicants must belong to one of the following categories:
- Tenure-track** Assistant Professors within the first three years of obtaining their initial Assistant Professor position. (Cut-off date: June 1, 2006.) *
- [**Stanford Clarification: ONLY Assistant professors with UTL and MCL faculty appointments are eligible. Any institutional letter for MCL faculty must explain the rigorous appointment process as well as the institution's commitment to the applicant.]
- [Stanford Clarification: Postdocs, Clinical Fellows and Instructors are NOT eligible.]
- [Stanford Clarification: Clinical educator line faculty, Clinical Assistant, Clinical Associate and Clinical Professors and Clinical Instructors are not eligible, per Stanford PIship policies, to be PIs for sponsored projects.
- Applicants must commit a minimum of 80% of their time to conducting research.
- Applicants may apply no more than two times.
- Applicants must demonstrate that they have access to the resources and infrastructure necessary to conduct the proposed research.
- The department must guarantee the Investigator is conducting the proposed research independently.
- Such individuals should have an exceptional record of research accomplishment, dedicated laboratory space, and the support of their institutions.
- Concurrent Funding
Since the goal of the Innovation Award is to fund high risk/high reward research that lacks sufficient preliminary data to secure traditional funding, the applicant should not have funding for this proposed project. - During the course of the award, award recipients are encouraged to seek additional funding to expand and further develop their projects.
Selection criteria
Applications will be evaluated based on the following:
The applicant’s capacity to conduct bold, exceptionally creative research.
The novelty and potential for breakthrough innovation of the proposed research.
The likelihood that, if successful, the proposed research will lead to significant advances that will impact the prevention, diagnosis, treatment, or basic understanding of cancer.
The applicant’s lack of resources to pursue the proposed research.
Questions?
Please contact Jeanne Heschele at jheschele@stanford.edu.
